9th Annual Biomarkers Congress

View Profile


Grant Support

Start year End year Title Source Position
1. 2009 Present Comparative Analysis of Surgical Treatment Options for Localized Prostate Cancer NIH/NCI Principle Investigator
2. 2006 Present Neoadjuvant chemo-hormonal therapy followed by radical prostatectomy versus radical prostatectomy alone in high risk patients CALGB Protocol Principal Investigator
3. 2001 Present Development of Models for Outcomes Prediction in Early-Stage Prostate Cancer using Molecular and Clinical Variables NIH/NCI Investigator
4. 2006 2007 Phase II Placebo Controlled Trial of Preoperative Lycopene Supplementation in Prostate Cancer Patients Division of Cancer Prevention Principal Investigator
5. 2004 2005 Novel Protein Microarray Technology to Examine Men with Prostate Cancer DOD CDMRP Co-Principal Investigator
6. 1996 2001 Southwest Oncology Group UCOP Principal Investigator
7. 1999 2000 Chemoprevention of prostate cancer with a cyclooxygenase-2 inhibitor Biomedical Research Foundation Pilot Grant Principal Investigator.
8. 1997 1998 p53 Gene Therapy in a Human Model for Prostate Cancer. Canji Inc. Research Grant Principal Investigator
9. 1997 Molecular Markers of Progression in Human Transitional Cell Carcinoma Biomedical Research Foundation Pilot Grant Principal Investigator
10. 1995 1996 Adenovirus-mediated Gene Transfer in the Treatment of Prostate Cancer Biomedical Research Foundation Young Investigator Grant Principal Investigator
11. 1994 Gene Therapy in the Treatment of Human Prostate Cancer Lamar Fleming Research Grant Principal Investigator
12. 1993 1994 Molecular Markers for Prostate Cancer 1. Molecular Markers for Prostate Cancer. National Kidney Foundation/American Foundation for Urologic Disease Principal Investigator


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.